Literature DB >> 17877638

Arginine vasopressin increases glutamate release and intracellular Ca2+ concentration in hippocampal and cortical astrocytes through two distinct receptors.

Nasser Syed1, Catherine A Martens, Walter H Hsu.   

Abstract

Arginine vasopressin (AVP), released from the CNS, plays an important role in regulating several aspects of CNS functions including aggression, anxiety, and cognition. In this study, we report a novel finding that AVP induces glutamate release from astrocytes isolated from the cerebral cortex and hippocampus. We also investigated the types of AVP receptors involved in the AVP-induced increase in glutamate release from astrocytes isolated from the hippocampus and cortex of neonatal rats. We showed that the AVP (0.1-1000 nmol/L) induced increase in glutamate release and [Ca(2+)](i) is brought about by two distinct subtypes of V(1) receptors (V(1a) and V(1b)). Our results suggested that V(1b) receptors are predominantly expressed in astrocytes isolated from the hippocampus and V(1a) receptors are solely expressed in astrocytes isolated from the cerebral cortex of neonatal rats. The results of the western blot analyses confirmed these pharmacological data. In addition, the AVP-induced increase in glutamate did not contribute to an increase in [Ca(2+)](i), as blockade of metabotropic glutamate receptors did not alter the AVP-induced increase in [Ca(2+)](i). In addition, the administration of a phospholipase A(2) inhibitor failed to alter AVP-induced [Ca(2+)](i) increase suggesting the lack of involvement of this enzyme.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17877638     DOI: 10.1111/j.1471-4159.2007.04737.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

2.  Nutritional state-dependent ghrelin activation of vasopressin neurons via retrograde trans-neuronal-glial stimulation of excitatory GABA circuits.

Authors:  Juhee Haam; Katalin C Halmos; Shi Di; Jeffrey G Tasker
Journal:  J Neurosci       Date:  2014-04-30       Impact factor: 6.167

3.  Arginine vasopressin inhibits adipogenesis in human adipose-derived stem cells.

Authors:  Tran D N Tran; Shaomian Yao; Walter H Hsu; Jeffrey M Gimble; Bruce A Bunnell; Henrique Cheng
Journal:  Mol Cell Endocrinol       Date:  2015-02-16       Impact factor: 4.102

4.  Antagonists of the Vasopressin V1 Receptor and of the β(1)-Adrenoceptor Inhibit Cytotoxic Brain Edema in Stroke by Effects on Astrocytes - but the Mechanisms Differ.

Authors:  Leif Hertz; Junnan Xu; Ye Chen; Marie E Gibbs; Ting Du; Leif Hertz; Junnan Xu; Ye Chen; Marie E Gibbs; Ting Du
Journal:  Curr Neuropharmacol       Date:  2014-07       Impact factor: 7.363

Review 5.  Sex Differences in the Regulation of Offensive Aggression and Dominance by Arginine-Vasopressin.

Authors:  Joseph I Terranova; Craig F Ferris; H Elliott Albers
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-14       Impact factor: 5.555

6.  Activation of Preoptic Arginine Vasopressin Neurons Induces Hyperthermia in Male Mice.

Authors:  Iustin V Tabarean
Journal:  Endocrinology       Date:  2021-02-01       Impact factor: 4.736

7.  Arginine vasopressin altered the expression of monocarboxylate transporters in cultured astrocytes isolated from stroke-prone spontaneously hypertensive rats and congenic SHRpch1_18 rats.

Authors:  Kazuo Yamagata; Natsumi Takahashi; Nozomi Akita; Toru Nabika
Journal:  J Neuroinflammation       Date:  2017-09-02       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.